Codexis

Codexis Current Assets

The Current Assets of Codexis (CDXS) as of Sep 26, 2026 is 86.09 M USD. In the previous year, Current Assets was 98.77 M USD — a change of -12.84% (lower).

Current Assets

86.09 MUSD

YoY

-12.84%

Last updated:

Current Assets of Codexis is 2026 86.09 M USD. Current Assets of Codexis was 2025 98.77 M USD. It decreases by -12.84% lower compared to the previous year.

The Codexis Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
68.20 M USD
Jan 1, 2019
114.25 M USD
Jan 1, 2020
184.44 M USD
Jan 1, 2021
161.94 M USD
Jan 1, 2022
162.92 M USD
Jan 1, 2023
93.47 M USD
Jan 1, 2024
98.77 M USD
Jan 1, 2025
86.09 M USD
The Codexis Current Assets history
YEARCurrent AssetsYoY
86.09 MUSD-12.84%
98.77 MUSD+5.68%
93.47 MUSD-42.63%
162.92 MUSD+0.61%
161.94 MUSD-12.20%
184.44 MUSD+61.43%
114.25 MUSD+67.53%
68.20 MUSD+51.42%
45.04 MUSD+65.57%
27.20 MUSD-17.09%
32.81 MUSD-0.69%
33.04 MUSD-7.64%
35.77 MUSD-40.11%
59.72 MUSD-24.61%
79.22 MUSD-14.05%
92.16 MUSD+36.86%
67.34 MUSD+39.29%
48.34 MUSD-48.20%
93.31 MUSD+154.33%
36.69 MUSD—
Access this data via the Eulerpool API

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codexis stock

Current Assets of Codexis is 86.09 M USD in 2026.

Current Assets of Codexis changed from 98.77 M USD to 86.09 M USD, representing a -12.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Codexis since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Codexis historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Codexis

All Key Metrics — Codexis